News Related to Small-Molecule Drugs

Related coverage linked through entity extraction aliases.

Junshi Biosciences Reports 28% Revenue Growth in 2025; Absci Schedules Q4 Results

Mar 13, 2026

Junshi Biosciences reported total revenue of approximately RMB2,498 million in 2025, a 28% increase year-over-year, driven by toripalimab sales growth. Absci Corporation announced it will report fourth quarter and full year 2025 financial results on March 24, 2026.

Blood-Brain Barrier Remains Major Obstacle for Brain Tumor and CNS Therapies

Mar 13, 2026

The blood-brain barrier continues to block most treatments for glioblastoma and central nervous system diseases, with only 0.01% of biologic drugs reaching the brain. New intellectual property coverage and synthetic methods aim to address delivery challenges.